Symbols / EIGR
EIGR Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split - PR Newswire hu, 04 Jan 2024 08
- Eiger BioPharmaceuticals (EIGR): The Results Are In - The CEO And The CFO Are Out - Seeking Alpha Fri, 17 Feb 2023 08
- Why Is Sigma Lithium (SGML) Stock Up 14% Today? - InvestorPlace Wed, 13 Sep 2023 07
- Eiger BioPharmaceuticals confirms chapter 11 liquidation plan - Investing.com Mon, 09 Sep 2024 07
- Eiger BioPharmaceuticals Enters into $75M Term Loan Agreement and $5M Stock Purchase Agreement with Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Position Ahead of Key Milestones - PR Newswire ue, 07 Jun 2022 07
- Billionaire David Shaw Pours Money Into 3 “Strong Buy” Stocks - TipRanks Wed, 09 Sep 2020 07
- Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock - PR Newswire Sun, 15 Oct 2017 01
- Eiger BioPharmaceuticals Announces Sale of Non-Strategic Assets to Theragene Pharmaceuticals - PR Newswire hu, 29 Jun 2017 07
- Eiger BioPharmaceuticals Closes Merger With Celladon - PR Newswire ue, 22 Mar 2016 07
- Eiger BioPharmaceuticals Announces License of Worldwide Rights to Pegylated Interferon Lambda-1a from Bristol-Myers Squibb - PR Newswire Wed, 20 Apr 2016 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for EIGR
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|